News stories about Phibro Animal Health Corporation (NASDAQ:PAHC) have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Phibro Animal Health Corporation earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave media stories about the company an impact score of 46.7866694763569 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

A number of research firms have recently issued reports on PAHC. Piper Jaffray Companies reiterated a “buy” rating and set a $42.00 price target on shares of Phibro Animal Health Corporation in a research report on Friday, November 10th. ValuEngine downgraded shares of Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, November 9th. Zacks Investment Research downgraded Phibro Animal Health Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, November 8th. Credit Suisse Group lifted their price objective on Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an “outperform” rating in a research report on Thursday, August 31st. Finally, Bank of America Corporation restated an “underperform” rating and set a $33.00 price objective on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $38.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) traded down $0.60 during mid-day trading on Wednesday, reaching $35.15. 47,016 shares of the company’s stock traded hands, compared to its average volume of 115,710. The stock has a market cap of $1,402.39, a PE ratio of 22.81, a P/E/G ratio of 4.09 and a beta of 1.35. The company has a debt-to-equity ratio of 1.91, a current ratio of 3.26 and a quick ratio of 1.85. Phibro Animal Health Corporation has a 12-month low of $26.10 and a 12-month high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.01. Phibro Animal Health Corporation had a net margin of 8.87% and a return on equity of 42.75%. The company had revenue of $193.40 million during the quarter, compared to analysts’ expectations of $189.89 million. During the same period in the previous year, the company earned $0.36 EPS. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. equities analysts anticipate that Phibro Animal Health Corporation will post 1.57 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be paid a dividend of $0.10 per share. The ex-dividend date is Tuesday, December 5th. This represents a $0.40 annualized dividend and a dividend yield of 1.14%. Phibro Animal Health Corporation’s dividend payout ratio is presently 23.53%.

In related news, insider Dean J. Warras sold 10,000 shares of Phibro Animal Health Corporation stock in a transaction on Friday, September 15th. The shares were sold at an average price of $35.70, for a total transaction of $357,000.00. Following the transaction, the insider now owns 10,000 shares in the company, valued at approximately $357,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gerald K. Carlson sold 5,400 shares of Phibro Animal Health Corporation stock in a transaction on Monday, September 11th. The shares were sold at an average price of $36.27, for a total transaction of $195,858.00. Following the transaction, the director now owns 5,400 shares in the company, valued at approximately $195,858. The disclosure for this sale can be found here. Insiders have sold a total of 279,791 shares of company stock valued at $10,118,331 over the last three months. Corporate insiders own 51.88% of the company’s stock.

WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-phibro-animal-health-corporation-pahc-stock-price/1720538.html.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.